Evidence map›Paper›PMID 11917012›Full record

ArticleNucleic acids research2002

Requirements for utilization of CREB binding protein by hypersensitive site two of the beta-globin locus control region.

Kirby D Johnson, Jason E Norton, Emery H Bresnick

Open access · bronzeAbstract read
In one paragraph

Article in Nucleic acids research, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 8 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Kirby D JohnsonUniversity of Wisconsin Medical School, Department of Pharmacology, Molecular and Cellular Pharmacology Program, 383 Medical Science Center, 1300 University Avenue, Madison, WI 53706, USA.
Jason E Norton
Emery H Bresnick
University of Wisconsin–Madison · US

Funding

COACTIVATORS THAT MEDIATE BETA GLOBIN LCR FUNCTIONR01DK055700 · NIDDK · UNIVERSITY OF WISCONSIN-MADISON · PI BRESNICK, EMERY H. · 1999 to 2006
$1.8M
NIDDK NIH HHS DK55700NIDDK NIH HHS R01 DK055700
6 · The paper itself

Abstract

Strong transactivation of the beta-globin genes is conferred by the beta-globin locus control region (LCR), which consists of four erythroid-specific DNase I hypersensitive sites (HS1-HS4). HS2 has a powerful enhancer activity dependent upon tandem binding sites for the erythroid cell- and megakaryocyte-specific transcription factor NF-E2. An important co-activator-mediating transactivation by HS2 is the histone acetyltransferase (HAT) CREB binding protein (CBP). We showed previously that recruitment of a GAL4-CBP fusion protein to HS2 largely bypassed the requirement of the NF-E2 sites for transactivation. To determine whether GAL4-CBP recruitment is sufficient for transactivation, we assessed the importance of cis-elements within HS2. Docking of GAL4-CBP upstream of an Agamma-globin promoter lacking HS2 only weakly activated the promoter, indicating that HS2 components are required for GAL4-CBP-mediated transactivation. Sequences upstream and downstream of the NF-E2 sites were required for maximal GAL4-CBP-mediated transactivation, and HAT catalytic activity of GAL4-CBP was critical. No single factor-binding site was required for GAL4-CBP-mediated transactivation. However, deletion of two sites, a CACC site and an E-box, abolished transactivation in transient and stable transfection assays. These results suggest that NF-E2 recruits CBP as a critical step in transactivation, but additional components of HS2 are required to achieve maximal enhancer activity.

Indexed as

Saccharomyces cerevisiae ProteinsAcetyltransferasesBase SequenceBinding SitesCREB-Binding ProteinDNA-Binding ProteinsErythroid-Specific DNA-Binding FactorsGlobinsHistone AcetyltransferasesHumansK562 CellsMolecular Sequence DataNF-E2 Transcription FactorNF-E2 Transcription Factor, p45 SubunitNuclear ProteinsPlasmidsAcetyltransferasesCREB-Binding ProteinCREBBP protein, humanDNA-Binding ProteinsErythroid-Specific DNA-Binding FactorsGlobinsHistone AcetyltransferasesNFE2 protein, humanNF-E2 Transcription FactorNF-E2 Transcription Factor, p45 SubunitNuclear ProteinsRecombinant Fusion ProteinsSaccharomyces cerevisiae ProteinsTrans-ActivatorsTranscription Factors

Identifiers

PMID11917012
PMCPMC101831
OpenAlexW2117262774

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.